Showing results (81-90 of 1,988) with videos related to
Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|November 2, 2011
Utility of PCA3 in patients undergoing repeat biopsy for prostate cancerA K Wu, A C Reese, M R Cooperberg, et al.Prostate Cancer and Prostatic Diseases|May 27, 2009
First-year costs of treating prostate cancer: estimates from SEER-Medicare dataC G Roehrborn, P Albertsen, M E Stokes, et al.Prostate Cancer and Prostatic Diseases|May 27, 2009
Effect of selective estrogen receptor modulators on cell proliferation and estrogen receptor activities in normal human prostate stromal and epithelial cellsH Nomura, H Kawashima, S Masaki, et al.Prostate Cancer and Prostatic Diseases|June 24, 2009
Lymph node dissection during robot-assisted radical prostatectomy: where do we stand?J L Silberstein, I H Derweesh, C J KaneProstate Cancer and Prostatic Diseases|July 15, 2009
Measuring therapeutic efficacy in the changing paradigm of castrate-resistant prostate cancerP F Mulders, J A SchalkenProstate Cancer and Prostatic Diseases|July 15, 2009
Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteersM Tanaka, K Fujimoto, Y Chihara, et al.Prostate Cancer and Prostatic Diseases|December 21, 2011
Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behaviorG Gueron, A De Siervi, E VazquezProstate Cancer and Prostatic Diseases|December 21, 2011
Body mass index and risk of BPH: a meta-analysisS Wang, Q Mao, Y Lin, et al.Prostate Cancer and Prostatic Diseases|February 29, 2012
MTHFR polymorphism and the risk of prostate cancer: a meta-analysis of case-control studiesX-L Li, J-H XuProstate Cancer and Prostatic Diseases|October 1, 2008
Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasiaJ Hammarsten, J-E Damber, M Karlsson, et al.Pageof 199